Performance of UTHR United Therapeutics | 32.4% in 12m

Compare UTHR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare United Therapeutics with its related Sector/Index XBI

Compare United Therapeutics with its related Sector/Index XBI

Performance Duell UTHR vs XBI

TimeFrame UTHR XBI
1 Day -0.84% -2.26%
1 Week 1.48% -0.43%
1 Month 7.39% 8.88%
3 Months 38.7% 16.99%
6 Months 50.0% 12.18%
12 Months 32.4% 14.95%
YTD 44.6% 8.24%
Rel. Perf. 1m 0.44
Rel. Perf. 3m 3.72
Rel. Perf. 6m 3.01
Rel. Perf. 12m 3.01

Is United Therapeutics a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, United Therapeutics (NASDAQ:UTHR) is currently (July 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 77.00 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTHR as of July 2024 is 366.77. This means that UTHR is currently undervalued and has a potential upside of +11.59% (Margin of Safety).

Is UTHR a buy, sell or hold?

  • Strong Buy: 8
  • Buy: 4
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
United Therapeutics has received a consensus analysts rating of 4.19. Therefor, it is recommend to buy UTHR.
Values above 0%: UTHR is performing better - Values below 0%: UTHR is underperforming

Compare UTHR with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 2.17% 6.30% 33.28% 8.47%
US NASDAQ 100 QQQ 4.01% 8.41% 33.56% 3.87%
US Dow Jones Industrial 30 DIA -0.81% 2.64% 40.53% 14.84%
German DAX 40 DBXD 2.41% 6.17% 39.68% 21.08%
UK FTSE 100 ISFU 1.32% 4.89% 35.49% 20.85%
Shanghai Shenzhen CSI 300 CSI 300 0.77% 8.17% 42.27% 40.44%
Hongkong Hang Seng HSI 1.54% 9.35% 48.75% 48.05%
Japan Nikkei 225 EXX7 5.56% 5.17% 45.58% 23.34%
India NIFTY 50 INDA 1.02% 4.44% 33.56% 3.57%
Brasil Bovespa EWZ 4.49% 3.62% 61.86% 41.44%

UTHR United Therapeutics vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 2.75% 5.38% 33.59% 0.65%
Consumer Discretionary XLY 1.23% 2.38% 40.13% 20.69%
Consumer Staples XLP -0.13% 5.90% 39.95% 25.74%
Energy XLE -1.95% 1.19% 31.24% 17.91%
Financial XLF -1.01% 2.08% 33.14% 7.51%
Health Care XLV 1.64% 6.17% 43.65% 22.67%
Industrial XLI -0.21% 5.08% 36.88% 15.93%
Materials XLB 0.05% 5.36% 38.40% 21.63%
Real Estate XLRE -0.69% 0.91% 42.38% 23.54%
Technology XLK 4.65% 10.26% 34.93% 4.02%
Utilities XLU 2.46% 5.35% 33.40% 26.57%
Aerospace & Defense XAR 0.09% 4.48% 37.22% 12.97%
Biotech XBI 1.91% -1.49% 37.82% 17.45%
Homebuilder XHB -3.97% -0.26% 30.86% -5.03%
Retail XRT 1.52% 6.37% 37.36% 14.89%

UTHR United Therapeutics vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 2.76% 5.83% 34.30% 16.59%
Natural Gas UNG 8.77% 36.63% 86.56% 83.88%
Gold GLD 0.35% 2.61% 29.50% 8.47%
Silver SLV 6.64% 6.50% 19.29% 11.89%
Copper CPER 6.63% 11.54% 36.67% 19.79%

Returns of UTHR vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 1.55% 8.26% 48.35% 36.91%
iShares High Yield Corp. Bond HYG 1.15% 5.97% 45.52% 22.41%
Does United Therapeutics outperform its market, is UTHR a Sector Leader?
Yes, over the last 12 months United Therapeutics (UTHR) made 32.40%, while its related Sector, the SPDR S&P Biotech (XBI) made 14.95%.
Over the last 3 months UTHR made 38.72%, while XBI made 16.99%.
Period UTHR XBI S&P 500
1 Month 7.39% 8.88% 1.09%
3 Months 38.72% 16.99% 11.00%
12 Months 32.40% 14.95% 23.93%